SADDLE BROOK, N.J.--(BUSINESS WIRE)--CircuLite®, Inc. today announced the SYNERGY® Circulatory Support System will be included in two presentations at the 26th Annual Meeting of the European Association for Cardio-Thoracic Surgery (EACTS), which is being held October 27-31, 2012 in Barcelona, Spain. CircuLite recently announced CE Marking approval for the SYNERGY® System, which is a micro-pump designed to halt the progression of heart failure and to improve symptoms and exercise tolerance. By working with the heart’s native pumping capacity, the SYNERGY System is specifically targeted for treatment of ambulatory heart failure patients (INTERMACS 4,5,6 / NYHA III and early IV) who remain symptomatic despite standard medical management.
CircuLite and the SYNERGY Circulatory Support System will be discussed in the following presentations:
- Alessandro Barbone, M.D., Ph.D., of Istituto Clinico Humanitas (Rozzano, Italy), will present “Circulatory Support in Elderly Chronic Heart Failure Patients Using the CircuLite® SYNERGY® System” during the ‘Mechanical support of the circulation’ scientific session on Monday, October 29 at 11:15 a.m. CET.
- Filip Rega, M.D., Ph.D., Associate Professor and Assistant Head of Clinic at the Department of Surgery, University Hospital (Leuven, Belgium), will present “Clinical Experience With the Current CircuLite® SYNERGY® System in Chronic Ambulatory Heart Failure” during the ‘Extracorporeal life support’ scientific session on Tuesday, October 30 at 10:15 a.m. CET.
Additionally, CircuLite will be an exhibitor at EATCS. Representatives will be available at booth 4 in the exhibition hall.
About the SYNERGY® Circulatory Support System
The SYNERGY Circulatory Support System is a micro-blood pump that provides up to 4.25 liters of blood per minute and reduces the heart's workload, while improving blood flow to vital organs. The system is surgically implanted using a mini-thoracotomy and is placed in a pacemaker-like pocket. In a clinical study, SYNERGY improved hemodynamics, exercise capacity, and overall quality of life. SYNERGY is designed and manufactured in Aachen, Germany.
CircuLite is developing disruptive solutions to improve the treatment of heart failure. The Company’s technologies work in conjunction with the heart to enhance clinical outcomes and improve quality of life. SYNERGY®, which recently received CE Marking approval, features the smallest surgically implanted blood pump for long-term use in patients with heart failure not responding to standard medical treatment. For more information, visit our website at www.circulite.net.
CAUTION: Investigational Device. Limited by United States Law to Investigational Use Only.
CircuLite® and SYNERGY® are registered trademarks of CircuLite, Inc. in the United States.